Serum lipids of pemphigus foliaceus patients on long-term glucocorticoid therapy.

Autor: da Cunha SF; Department of Internal Medicine, Faculdade de Medicina do Triângulo Mineiro, Uberaba., dos Santos VM, Monteiro JP, Ferreira TP, dos Santos JA, dos Santos TA, da Cunha DF
Jazyk: angličtina
Zdroj: Revista da Sociedade Brasileira de Medicina Tropical [Rev Soc Bras Med Trop] 2003 Jan-Feb; Vol. 36 (1), pp. 1-4. Date of Electronic Publication: 2003 Apr 22.
DOI: 10.1590/s0037-86822003000100001
Abstrakt: Endemic pemphigus foliaceus, and long-term corticotherapy may affect serum lipid levels. The aim of this study was to compare serum lipids of pemphigus foliaceus patients on glucocorticoid therapy to a healthy control group. Fifteen patients receiving prednisone (0.33 +/- 0.22 mg/kg) for at least 12 months and 15 controls were submitted to 48-h food intake records, anthropometry, and biochemical measurements. Data were compared by chi2, Mann-Whitney and Student "t" tests. The groups were matched for gender, age, weight, body mass index, arm circumference and triceps skin fold. No differences were observed in relation to energy, fat, protein and carbohydrate daily intakes, total cholesterol, HDL, LDL, uric acid, and serum creatinine levels. Pemphigus foliaceus patients had higher triglyceride [159 (64-371) vs. 100 (45-133) mg/dl], VLDL [32 (13-74) vs. 20 (9-114) mg/dl] and ESR [44 (9-87) vs. 7 (1-30) mm/h] levels than controls, probably due to metabolic effects of inflammatory disease and corticotherapy.
Databáze: MEDLINE